Abstract
A portable fluorescence detection system for use with microchip electrophoresis was developed and compared to a benchtop system. Using this system, six neuroactive amines commonly found in brain dialysate—arginine, citrulline, taurine, histamine, glutamate, and aspartate—were derivatized offline with naphthalene-2,3-dicarboxaldehyde/cyanide, separated electrophoretically, and detected by fluorescence. Limits of detection for the analytes of interest were 50nM – 250nM for the benchtop system and 250 nM – 1.3 μM for the portable system, both of which were adequate for analyte determination in brain microdialysis samples. The portable system was then demonstrated for the detection of the same six amines in a rat brain microdialysis sample.
Keywords: Microchip electrophoresis; amino acid neurotransmitter; microdialysis; fluorescence detection; naphthalene-2,3-dicarboxaldehyde; neuroactive amine
Introduction
Microdialysis (MD) is a popular in vivo sampling method that has been used to monitor neurotransmitters in both animal models and humans. In particular, microdialysis sampling has been used to monitor chemicals in the brains of traumatic brain injury patients in intensive care units (ICU). In cases of severe traumatic brain injury or acute ischemic stroke1–3, MD sampling can be used to monitor the extent of tissue damage and the efficacy of treatment simultaneously using continuous and long-term sampling of multiple biomarkers.
A MD probe works via the interaction of a sterile perfusate fluid, artificial cerebral spinal fluid (aCSF) in the case of brain MD, with the extracellular fluid of a tissue through a semi-permeable membrane. As perfusate flows into the probe, analytes in the extracellular fluid that are smaller than the pore size of the membrane diffuse into the perfusate according to their concentration gradients. The analyte-laden perfusate, or dialysate, is then collected for analysis. Despite the continuous nature of the sampling that MD provides, analysis is often performed off-line. Consequently, the recovery of any analyte of interest is governed by the flow rate of the perfusate liquid4. At a flow rate of 1 μL /min, typical analyte recoveries for small molecules are in the range of 10–40%. Lower flow rates result in higher analyte recoveries, approaching 100% at 100 nL /min, but with smaller volumes of dialysate collected per unit time5,6. This tradeoff dictates which analytical technique can be used and how often analysis can be performed.
Typically, MD samples are collected until sufficient volumes are acquired to allow the use of the desired analytical method with requisite sensitivity and selectivity. The most common method employed for the analysis of microdialysis samples is liquid chromatography (LC) coupled to electrochemical, fluorescence, mass spectrometry (MS), or absorbance detection7. However, the time required to obtain a dialysate sample large enough for many LC-based assays can reduce the temporal resolution of the technique as well as add a significant delay between sample acquisition and clinical response. In order to address a clinical need for an analytical technique that can continuously analyze small volume samples, and selectively detect very low analyte concentrations with good temporal resolution, several groups have developed on-line MD methods using capillary (CE) and microchip electrophoresis (ME)8,9. These systems, when combined with a sensitive detection method, such as laser- (or light emitting diode-) induced fluorescence (ME-LIF and ME-LEDIF), can rapidly analyze nanoliter-volume samples in a continuous manner, providing clinicians with near real-time data.
There are many examples of the use of CE to monitor amino acid neurotransmitters in microdialysis samples10–15 and other examples have been reviewed by Poinsot et al.16 However, these systems typically use off-line sample collection and precolumn derivatization, requiring samples large enough to be handled accurately off-line. Coupling CE or ME directly to MD makes it possible for much smaller samples volumes to be analyzed, leading to better temporal resolution as long as the method displays the requisite sensitivity17. To this end, our group previously developed a polydimethylsiloxane (PDMS)-based microchip electrophoresis device that was coupled to microdialysis (MD-ME) for continuous on-line monitoring of amino acid neurotransmitters14,15. The microchip was completely integrated with the MD sampling system, which provided on-line derivatization of the amino acids with naphthalene-2,3-dicarboxyaldehyde/cyanide (NDA/CN−), a flow-gate interface for injection, and electrophoresis separation using a serpentine channel with LIF detection. Although the chip itself was small, the associated instrumentation needed for fluorescence detection was quite large and thus not amenable to a clinical setting.
The aim of the present work is to expand on the theme of miniaturization and integration of on-line MD-ME-LIF device with the goal of a system that can be for used near real-time monitoring of amine-based neurotransmitters in the ICU or research laboratory. The particular focus of this report is miniaturization of the fluorescence detection system. To evaluate the system, figures of merit for the separation and detection of several NDA/CN-derivatized amines commonly found in rat brain dialysate were determined using a conventional benchtop ME-LIF system employing an epifluoresence microscope. These results were then compared to those obtained using the newly developed portable ME-LEDIF system. The portable system described here could potentially be placed near patients in an ICU (or next to animals for animal studies), permitting continuous near real-time monitoring of these neuroactive amines in injured brain tissue to assess damage and monitor treatment.
Experimental
Reagents and chemicals
Arginine (Arg), aspartate (Asp), citrulline (Cit), glutamate (Glu), histamine (Hist), and taurine (Tau) were obtained from Sigma Aldrich (St Louis, MO). Standards of each amine were prepared at 2 mM concentrations in 18.2 MΩ /cm deionized water (Millipore, Billerica, MA). Subsequent dilutions of each stock solution were made prior to analysis. Naphthalene-2,3-dicarboxaldehyde (NDA) (Invitrogen, Carlsbad, CA) was prepared in acetonitrile (Fisher Scientific, Pittsburgh, PA) to a concentration of 5 mM. Sodium cyanide (NaCN) (Sigma Aldrich) was dissolved in water to a final concentration of 10 mM. Stock solutions of both NDA and NaCN were made weekly and stored at 4°C, protected from light exposure. Stock solutions of sulfobutylether-β-cyclodextrin (SBEC) (Life Technologies, Grand Island NY) were made on a weekly basis to a concentration of 10 mM in deionized water and stored at 4°C. Finally, the background electrolyte (BGE) consisted of 1.4 mM SBEC, 10% by volume HPLC-grade dimethylsulfoxide (Fisher Scientific), and sodium tetraborate (Sigma Aldrich) at a final concentration of 15 mM. Finally, the pH of the BGE was measured using a pH meter and adjusted to 9.2 with 1 M sodium hydroxide (Fisher Scientific).
Animal surgery and microdialysis sampling
Male Sprague-Dawley rats were housed in temperature-controlled rooms with free access to food and water prior to surgery. Rats were fully anesthetized prior to surgery through inhalation of isofluorane followed by injection of a mixture of ketamine (67.5 mg/kg), xylazine (3.4 mg/kg), and acepromazine (0.67 mg/kg). To maintain anesthesia throughout the surgery, doses of ketamine were administered by intramuscular injections. Body temperature was maintained using a Homeothermic Blanket Control unit (Harvard Apparatus, Holliston, MA) set at 37°C, and rats were given saline doses to keep them hydrated. All surgical instruments were sterilized before usage and after the surgical procedures. A guide cannula followed by a microdialysis probe with a 4 mm membrane was inserted in the striatum region at stereotaxic coordinates A/P +0.7, M/L -−2.7, V/D −3.414,18. Microdialysis samples were collected by perfusing the probe (CMA, North Chelmsford, MA) with an artificial spinal fluid (aCSF) at 1 μL /min. Animal experiments were performed in accordance with regulations of the Institutional Animal Care and Use Committee (IACUC) at the University of Kansas, which operates with accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC).
Derivatization reaction
Derivatization of the amino acid standards and MD sample was carried out using equal parts by volume of 5 mM NDA and 10 mM NaCN, 15 mM boric buffer (pH 9.2), and sample. NDA reacts with primary amines in the presence of cyanide to produce fluorescent 1-cyanobenz[f]isoindole (CBI) products.
Microchip Electrophoresis (ME)
The glass microfluidic devices used in these studies were fabricated using standard photolithographic techniques as reported previously19,20. To separate the six target analytes, a 15-cm serpentine separation channel with 3-cm side channels (Fig. 1) was used. All channels were 15 μm deep and approximately 70 μm wide. Before each use, the chip was conditioned with 0.1 M HCl, water, 0.1 M NaOH, and then water again. Each solution was passed through the microchannels for 10 min via the application of negative pressure to one of the ports. Finally, the channels were filled with BGE using the same negative pressure procedure prior to use.
Fig. 1.
Top: 15 cm-length serpentine chip design with 2.7 cm-length side channels for sample waste and buffer, 0.5 cm length for sample inlet. All channels were 15 μm deep by 70 μm wide. Bottom: The actual glass chip used for size reference.
An UltraVolt HV Rack high-voltage power supply (Ronkonkoma, NY) was employed for the electrophoresis experiments and controlled by software written in Labview (National Instruments, Austin, TX). In these experiments, a voltage of 10 kV was applied at the buffer reservoir and 7 kV at the sample reservoir for an overall separation field strength of 420 V /cm. For the sample electrokinetic injection, the injection time was 0.7 s and the analysis time lasted 420 s.
Benchtop ME-LIF system
Fluorescence was chosen as the detection method in these studies because it provides high sensitivity and, in the case of NDA/CN derivatization, selectivity for primary amines.21 The cyanobenz(f)isoindole products of the NDA/CN reaction exhibit two excitation maxima in the visible range at approximately 420 nm and 442 nm22,23. For the benchtop ME system used in these studies, excitation was accomplished using either a 445 nm PhoxX diode laser (Market Tech, Scotts Valley, CA) or a 442 nm CL-2000 diode laser (Crystal Laser, Reno, NV). The excitation light source was coupled to an epifluorescence microscope (Nikon, Melville, NY) via a fiber optic cable; it was optically filtered using a 445 nm band pass filter and was focused on the separation channel approximately 0.2 cm from the waste reservoir via a long-pass dichroic mirror that directed the light to the chip and a 40× objective lens to focus onto the channel. The emission maxima for the products of the NDA/CN reaction occurs at 490 nm22. Once again, the epifluorescence microscope was used to focus the emission light through the long-pass dichroic mirror and long-pass edge filter (480 nm cutoff) before it was focused onto a photomultiplier tube (PMT). Signal acquisition from the PMT was performed using a National Instruments NI USB-6229 data acquisition card and Labview software, following amplification and low pass filtering with a 3 Hz filter cutoff using a model SR570 amplifier from Stanford Research Systems (Sunnyvale, CA). Origin software version 8.2 (Origin Lab Corporation, Northampton, MA) was used to analyze the subsequently collected data.
Portable ME-LEDIF system
The portable system has many commonalities with the benchtop ME system but also has several differences. As in the benchtop ME, fluorescence detection was accomplished by filtering and focusing excitation light on the separation channel followed by filtering and focusing subsequently emitted light on a detector. However, in the case of the portable system, a 420 nm LED (LED Engin, San Jose, CA) was used instead of a laser. The LED was powered using a custom current driver circuit and constructed using a frequency-controlled variable current driver, a MAX16836 (Maxim Integrated, San Jose CA), driven by an LM555 timer IC (Texas Instruments, Dallas TX). It was found that an input signal of 1.6 kHz resulted in a stable current output of 250 mA.
A microscope stage purchased from eBay is shown mounted in Fig. 2. This stage, which was originally designed to be motor driven, was modified using 3D-printed motor brackets to couple two NEMA 17 stepper motors to the stage. This allowed controlled movement in the X and Y directions as the optics mount moved along threaded rods while fixing the Z direction, such that the channel was at the focal point of a 100× objective. These motors were subsequently driven by a stepper motor driver shield for the Arduino microcontroller or, alternatively, could be manually adjusted.
Fig. 2a.
A close-up view of the portable system. 1. LED current driver board. 2. Optical mounting containing dichroic mirror, LED, objective lens, and optical filter. 3. Photodiode and preamplifier board. 4. Positioning motors, seen here from the side. 5. Arduino microcontroller with stacked motor driver shield and amplifier and analog to digital converter shield connected to preamplifier via white USB cable. The system itself measures 12” wide × 11” deep × 8” tall and weighs approximately 10 lbs.
As mentioned previously, an LED was employed as the excitation light source in the portable system and was mounted parallel to the chip. This LED was collimated using a plano-convex lens followed by spatial focusing via a 1 mm pinhole. The light from the LED was directed upward through an objective lens via a long-pass dichroic mirror with a 470 nm cutoff (Thorlabs, Newton NJ) and mounted at a 90° angle. Emission light was focused via the same objective lens through the long-pass dichroic mirror followed by a long-pass emission filter and was finally focused onto a detection point using a second plano-convex lens, model LA1951-A-N-BK7 (Thorlabs, Newton NJ). The final long-pass emission filter also had a cutoff of 470 nm (Thorlabs, Newton NJ), allowing light of any longer wavelength to pass on to the detector.
The detector itself consisted of an OPT301 combination transimpedance amplifier/silicon photodiode (Texas Instruments, Dallas, TX) in a custom circuit, mounted on a 1”-dia printed circuit board (PCB). This PCB was subsequently mounted in the optics holder such that the OPT301 was centered at the focal point of the plano-convex lens. This PCB was connected to the secondary amplifier via a 4-pin shielded USB cable which also supplied the OPT301 with power. Finally, the output of the OPT301 was amplified by a custom second stage amplifier circuit using an OPA726 IC (Texas Instruments) before passing the amplified signal to an analog-to-digital (ADC) converter, a Max11210 IC (Maxim Electronics, San Jose CA). The secondary amplification and ADC circuit was designed in the format of an Arduino shield, which allowed it to be easily interfaced with the open source Arduino Uno Microcontroller used for signal processing as well as communication to a nearby PC via USB. While future versions of the portable system will have integrated high voltage power supply for the separation as well as electrokinetic gates, the system used for this study relied on the UltraVolt HV Rack high-voltage power supply previously mentioned.
Results and Discussion
The on-line integration of MD to an analysis method such as ME-LEDIF has the potential to provide clinicians and animal researchers with minute-to-minute data regarding the tissue health of patients or to track changes in neurotransmitters in animal models. While several groups have successfully coupled MD to both CE20 and ME9,14, in practice, the benefits of doing so have been limited by the size of the associated equipment needed for the separation and detection. In an already crowded intensive care unit or neurobiology laboratory, this is a significant concern as any increased distance from the patient or animal could result in a significant delay in response due to low sample flow rates from the MD probe to the microchip. The goal of miniaturizing and creating the self-contained ME-LIF system described here is to reduce the time-lag between sampling and analysis as well as the overall size of the external equipment necessary. The aim is to create a small, portable detection system that can be placed near the patient or animal for near real-time monitoring.
To miniaturize the system as much as possible, several design decisions were made. The first of these was the choice of an LED excitation light source rather than a laser. There are three reasons for this. First, lasers are considerably more expensive than LEDs. Second, the mechanical robustness of the overall design was a consideration for portability and, typically, lasers are more fragile than LEDs. Finally, while we focused on NDA/CN derivatization in this study, the easy availability of a wide range of LED wavelengths for use in future studies with other fluorogenic compounds also influenced our decision to use an LED light source.
The requirements of portability and ruggedness also affected the physical/mechanical design of the system. Because microchip sizes and designs vary from application to application, and also because it is often necessary to move the chip for cleaning purposes, the alignment of the optics to the channel needed to be moveable in this portable system unlike those of other miniaturized systems18. Because a high voltage supply with wires leading to each port on the chip was necessary, moving the optics rather than the chip was the better option in order to avoid dislodging any the high voltage wires during alignment.
The use of the OPT301 photodiode for detection is another feature of this instrument. Other portable fluorescence detection systems24,25 have used a more sensitive, but ultimately more complex and costly PMT for detection. In this application, however, the use of a photodiode was adequate for the LODs required in these studies and simplified the design by eliminating the need for a high voltage supply for the PMT.
To evaluate the portable system for the determination of amines in microdialysis samples, it was necessary to compare the function of a traditional benchtop ME-LIF system to the portable ME-LEDIF system for the same set of analytes. For this purpose, a mixture of six neuroactive amines—arginine (Arg), citrulline (Cit), taurine (Tau), histamine (Hist), glutamate (Glu) and aspartate (Asp)—were derivatized using NDA/CN and electrophoretically separated using microchip electrophoresis. For each amine, the linearity over a range of physiologically relevant concentrations (Table 1) as well as limits of detection (LOD) and limits of quantification (LOQ) were determined using both systems. Following this, rat brain microdialysis samples were derivatized using NDA/CN and analyzed on both systems. For the purposes of these proof-of-concept tests, all samples were derivatized off-line for 30 min prior to separation.
Table 1.
| Benchtop system | Arg | Cit | Tau | Hist | Glu | Asp |
|---|---|---|---|---|---|---|
| Basal Physiological Range (μM)26–28 | .68 | .42 | 5–20 | .0047–.0067 | 8–22 | .8–1.6 |
| Calibration range (μM) | 0.1–10 | 0.1–10 | 0.1–10 | 0.1–10 | 0.1–10 | 0.1–10 |
| Regression coefficient (R2) | 0.9956 | 0.9897 | 0.9940 | 0.9990 | 0.9792 | 0.9854 |
| Limit of detection (S/N = 3) /μM | 0.05 | 0.05 | 0.05 | 0.05 | 0.25 | 0.05 |
| Limit of quantification (S/N = 10) /μM | 0.15 | 0.15 | 0.15 | 0.15 | 1.0 | 0.15 |
| Migration Time % RSD | 1.81 | 1.46 | 1.26 | 1.34 | 1.85 | 2.61 |
| Theoretical Plates /m | 746485 | 693960 | 872808 | 473232 | 565178 | 600081 |
| Peak Resolution | 1.29 | 1.16 | 0.97 | 1.15 | 1.10 | 0.15 |
| Portable system | ||||||
| Basal Physiological Range (μM)26–28 | .68 | .42 | 5–20 | .0047–.0067 | 8–22 | .8–1.6 |
| Calibration range (μM) | 2.0–50 | 2.0–50 | 2.0–25 | 2.0–15 | 2.0–50 | 2.0–50 |
| Regression coefficient (R2) | 0.9956 | 0.9834 | 0.9870 | 0.9977 | 0.9931 | 0.9904 |
| Limit of detection (S/N = 3) /μM | 0.25 | 0.36 | 0.42 | 0.37 | 1.31 | 1.21 |
| Limit of quantification (S/N = 10) /μM | 0.84 | 1.2 | 1.4 | 1.24 | 4.35 | 4.04 |
| Migration Time % RSD | 1.71 | 1.8 | 2.52 | 3.22 | 4.75 | 5.23 |
| Theoretical Plates /m | 275165 | 270431 | 331367 | 406943 | 325993 | 277798 |
| Peak Resolution | 2.53 | 0.96 | 1.01 | 6.09 | 2.00 | 3.08 |
As can be seen in Table 1, both systems exhibited a linear response over the physiologically relevant concentration ranges. The LOD for each amine can be found in Table 1. The LODs were lower for the benchtop ME-LIF, mainly due to the use of a PMT instead of a photodiode. Five of the six amines (Arg, Cit, Tau, Glu and Asp) could be detected and were present above the LODs determined with the portable system. The concentrations of aspartate and histamine were below the calculated LOQs and in the case of Hist, below the LOD. While a peak was consistently visible in the electropherogram, identified as Hist via standard spiking, the low nM extracellular concentration of Hist in the striatum imply two possibilities for this peak. The first is that a substantial increase in extracellular Hist has occurred due to tissue inflammation26. The second is the co-migration of an as yet unknown analyte. However, even though the benchtop ME-LIF system exhibited lower LODs (and LOQs) for five of the six amines, the performance of the portable system was adequate for detection of physiologically relevant concentrations of those five. Figure 3 (Bottom) shows an electropherogram obtained with the portable system for a representative microdialysis sample and (Top) the same sample spiked with 5 μM (final concentration) of amine standards. In this study, identification of the peaks was based on migration time and peak order.
Fig. 3.
(Top) MD Sample spiked with additional 5 μM Arg, Cit, Tau, Hist, Glu, and Asp. The identities of the peaks were determined based on migration time and order of the spiked sample compared to standards.
(Bottom) Electropherogram of a NDA/CN-derivatized microdialysate sample from striatum using the portable system.
Future work
Future versions of the system will address the need for automated positioning and variable chip sizes as well as further decrease the overall size of the system, which was larger than necessary in this design for convenience. As mentioned, the LOQs for two of the target analytes were too high for quantification in the microdialysis sample. In order to improve these LODs/LOQs, a programmable integrated circuit (PIC)-based (Microchip, Chandler AZ) lockin-amplifier system is being developed for fluorescence detection and integrated into the system along with a high voltage module for sample separation. The use of lower microdialysis flow rates and on-line derivatization to enhance analyte recovery and fluorescence product formation, respectively, are also being investigated. Finally, future studies will be conducted using online MD-ME sampling to look at amine changes in a rat ischemia model.
Figure 2b.
Portable system shown with Ultravolt high voltage supply and PC for scale.
Acknowledgements
Funding for this work was provided by a Biotechnology Training Grant T32 GM-08359 and NIH COBRE P20 GM103638 as well as NIH grant R01 NS042929. We would also like to thank Dr. Rachel Saylor for the microdialysis samples and Nancy Harmony for editorial assistance.
References
- (1).Deibert E, Diringer MN. Neurologist. 1999;5:313. [Google Scholar]
- (2).Kirkman MA, Citerio G, Smith M. Intensive Care Med. 2014;40:640. doi: 10.1007/s00134-014-3266-z. [DOI] [PubMed] [Google Scholar]
- (3).Persson L, Hillered L. J. Neurosurg. 1992;76:72. doi: 10.3171/jns.1992.76.1.0072. [DOI] [PubMed] [Google Scholar]
- (4).Stenken JA, Topp EM, Southard MZ, Lunte CE. Anal. Chem. 1993;65:2324. doi: 10.1021/ac00065a026. [DOI] [PubMed] [Google Scholar]
- (5).Nandi P, Lunte SM. Analytica chimica acta. 2009;651:1. doi: 10.1016/j.aca.2009.07.064. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (6).Menacherry S, Hubert W, Justice JB., Jr Anal. Chem. 1992;64:577. doi: 10.1021/ac00030a003. [DOI] [PubMed] [Google Scholar]
- (7).Davies MI, Cooper JD, Desmond SS, Lunte CE, Lunte SM. Adv. Drug Del. Rev. 2000;45:169. doi: 10.1016/s0169-409x(00)00114-9. [DOI] [PubMed] [Google Scholar]
- (8).Zhou SY, Zuo H, Stobaugh JF, Lunte CE, Lunte SM. Anal. Chem. 1995;67:594. doi: 10.1021/ac00099a017. [DOI] [PubMed] [Google Scholar]
- (9).Sandlin ZD, Shou M, Shackman JG, Kennedy RT. Anal. Chem. 2005;77:7702. doi: 10.1021/ac051044z. [DOI] [PubMed] [Google Scholar]
- (10).Tůma P, Šustková-Fišerová M, Opekar F, Pavlíček V, Málková K. J. Chromatogr. A. 2013;1303:94. doi: 10.1016/j.chroma.2013.06.019. [DOI] [PubMed] [Google Scholar]
- (11).Lorenzo M, Navarrete A, Balderas C, Garcia A. J. Pharm. Biomed. Anal. 2013;73:116. doi: 10.1016/j.jpba.2012.03.017. [DOI] [PubMed] [Google Scholar]
- (12).Male KB, Luong JH. J. Chromatogr. A. 2001;926:309. doi: 10.1016/s0021-9673(01)01056-1. [DOI] [PubMed] [Google Scholar]
- (13).Liu X, Yang L-X, Lu Y-T. J. Chromatogr. A. 2003;998:213. doi: 10.1016/s0021-9673(03)00637-x. [DOI] [PubMed] [Google Scholar]
- (14).Nandi P, Desai DP, Lunte SM. Electrophoresis. 2010;31:1414. doi: 10.1002/elps.200900612. [DOI] [PubMed] [Google Scholar]
- (15).Nandi P, Scott DE, Desai D, Lunte SM. Electrophoresis. 2013;34:895. doi: 10.1002/elps.201200454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (16).Poinsot V, Bayle C, Couderc F. Electrophoresis. 2003;24:4047. doi: 10.1002/elps.200305692. [DOI] [PubMed] [Google Scholar]
- (17).Saylor RA, Lunte SM. J. Chromatogr. A. 2015;1382:48. doi: 10.1016/j.chroma.2014.12.086. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (18).Mayer AP, Osorio I, Lunte CE. Epilepsy Behav. 2013;29:478. doi: 10.1016/j.yebeh.2013.08.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (19).Coltro WKT, Lunte SM, Carrilho E. Electrophoresis. 2008;29:4928. doi: 10.1002/elps.200700897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (20).Linz TH, Snyder CM, Lunte SM. J. Lab. Autom. 2012;17:24. doi: 10.1177/2211068211424551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (21).Culbertson CT, Mickleburgh TG, Stewart-James SA, Sellens KA, Pressnall M. Anal. Chem. 2013;86:95. doi: 10.1021/ac403688g. [DOI] [PMC free article] [PubMed] [Google Scholar]
- (22).De Montigny P, Stobaugh JF, Givens RS, Carlson RG, Srinivasachar K, Sternson LA, Higuchi T. Anal. Chem. 1987;59:1096. doi: 10.1021/ac00135a008. [DOI] [PubMed] [Google Scholar]
- (23).Melanson JE, Lucy CA. Analyst. 2000;125:1049. [Google Scholar]
- (24).Mora MF, Stockton AM, Willis PA. Electrophoresis. 2012;33:2624. doi: 10.1002/elps.201200102. [DOI] [PubMed] [Google Scholar]
- (25).Culbertson CT, Tugnawat Y, Meyer AR, Roman GT, Ramsey JM, Gonda SR. Anal. Chem. 2005;77:7933. doi: 10.1021/ac051198e. [DOI] [PubMed] [Google Scholar]
- (26).Adachi N, Itoh Y, Oishi R, Saeki K. Journal of Cerebral Blood Flow & Metabolism. 1992;12:477. doi: 10.1038/jcbfm.1992.65. [DOI] [PubMed] [Google Scholar]
- (27).Alabadí JA, Thibault J-L, Pinard E, Seylaz J, Lasbennes F. Brain Res. 1999;839:305. doi: 10.1016/s0006-8993(99)01749-7. [DOI] [PubMed] [Google Scholar]
- (28).Benveniste H. Journal of neurochemistry. 1989;52:1667. doi: 10.1111/j.1471-4159.1989.tb07243.x. [DOI] [PubMed] [Google Scholar]




